---
figid: PMC6386826__ijms-20-00500-g001
figtitle: Signaling transduction of mTOR pathway
organisms:
- Homo sapiens
- Mus musculus
- Molva molva
pmcid: PMC6386826
filename: ijms-20-00500-g001.jpg
figlink: /pmc/articles/PMC6386826/figure/ijms-20-00500-f001/
number: F1
caption: The signaling transduction of mTOR pathway. Extracellular signals such as
  growth factors and cytokines binding to the receptors stimulate RAS/RAF/MEK/ERK
  and PI3K/AKT/mTOR caspases. mTOR exists in two functionally and structurally distinct
  complexes, mTORC1 and mTORC2. Both mTORC1/2 contain different core components so
  they phosphorylate a distinct set of substrates and exhibit distinct function. PTEN
  is a negative regulator for PI3K/AKT. In addition, ERK/RSK, AMPK, and p53 regulate
  mTORC1 through TSC2 regulation. Rapalogs mainly inhibit mTORC1 and new-generation
  mTOR inhibitors such as MLN0128 inhibitor both mTORC1/2. Blue t-bar indicates inhibition,
  blue arrow indicates stimulation/activation, red t-bar indicates inhibition by drugs,
  and dashed square indicates mTOR1/2 complexes.
papertitle: mTOR Inhibitors in Advanced Biliary Tract Cancers.
reftext: Chao-En Wu, et al. Int J Mol Sci. 2019 Feb;20(3):500.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9655644
figid_alias: PMC6386826__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC6386826__F1
ndex: 8008a5bd-ded2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6386826__ijms-20-00500-g001.html
  '@type': Dataset
  description: The signaling transduction of mTOR pathway. Extracellular signals such
    as growth factors and cytokines binding to the receptors stimulate RAS/RAF/MEK/ERK
    and PI3K/AKT/mTOR caspases. mTOR exists in two functionally and structurally distinct
    complexes, mTORC1 and mTORC2. Both mTORC1/2 contain different core components
    so they phosphorylate a distinct set of substrates and exhibit distinct function.
    PTEN is a negative regulator for PI3K/AKT. In addition, ERK/RSK, AMPK, and p53
    regulate mTORC1 through TSC2 regulation. Rapalogs mainly inhibit mTORC1 and new-generation
    mTOR inhibitors such as MLN0128 inhibitor both mTORC1/2. Blue t-bar indicates
    inhibition, blue arrow indicates stimulation/activation, red t-bar indicates inhibition
    by drugs, and dashed square indicates mTOR1/2 complexes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cdkn2a
  - ras
  - Hras
  - Kras
  - Rem1
  - Mdm2
  - Zhx2
  - Trp53
  - pk
  - Mdk
  - Pten
  - Ephb2
  - Mapk1
  - Akt1
  - Tsc2
  - Tsc1
  - Rps6ka1
  - Mtor
  - Mlst8
  - Rptor
  - Rictor
  - Eif4e
  - Eif4ebp1
  - Rps6kb1
  - Sgk1
  - Pik3r1
  - Mapkap1
  - CDKN2A
  - KRAS
  - HRAS
  - NRAS
  - MDM2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TP53
  - TP63
  - TP73
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PTEN
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - TSC1
  - CCL26
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - MTOR
  - MLST8
  - RICTOR
  - RPTOR
  - MAPKAP1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - EIF4EBP1
  - SGK1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - Rapamycin
  - Sirolimus
  - Everolimus
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
